Cargando…

A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design

BACKGROUND: Epidemiology of HCV infection among drug users (DUs) has been widely studied. Prevalence and sociobehavioural data among DUs are therefore available in most countries but no study has taken into account in the sampling weights one important aspect of the way of life of DUs, namely that t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jauffret-Roustide, Marie, Le Strat, Yann, Couturier, Elisabeth, Thierry, Damien, Rondy, Marc, Quaglia, Martine, Razafandratsima, Nicolas, Emmanuelli, Julien, Guibert, Gaelle, Barin, Francis, Desenclos, Jean-Claude
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733898/
https://www.ncbi.nlm.nih.gov/pubmed/19607712
http://dx.doi.org/10.1186/1471-2334-9-113
_version_ 1782171112583462912
author Jauffret-Roustide, Marie
Le Strat, Yann
Couturier, Elisabeth
Thierry, Damien
Rondy, Marc
Quaglia, Martine
Razafandratsima, Nicolas
Emmanuelli, Julien
Guibert, Gaelle
Barin, Francis
Desenclos, Jean-Claude
author_facet Jauffret-Roustide, Marie
Le Strat, Yann
Couturier, Elisabeth
Thierry, Damien
Rondy, Marc
Quaglia, Martine
Razafandratsima, Nicolas
Emmanuelli, Julien
Guibert, Gaelle
Barin, Francis
Desenclos, Jean-Claude
author_sort Jauffret-Roustide, Marie
collection PubMed
description BACKGROUND: Epidemiology of HCV infection among drug users (DUs) has been widely studied. Prevalence and sociobehavioural data among DUs are therefore available in most countries but no study has taken into account in the sampling weights one important aspect of the way of life of DUs, namely that they can use one or more specialized services during the study period. In 2004–2005, we conducted a national seroepidemiologic survey of DUs, based on a random sampling design using the Generalised Weight Share Method (GWSM) and on blood testing. METHODS: A cross-sectional multicenter survey was done among DUs having injected or snorted drugs at least once in their life. We conducted a two stage random survey of DUs selected to represent the diversity of drug use. The fact that DUs can use more than one structure during the study period has an impact on their inclusion probabilities. To calculate a correct sampling weight, we used the GWSM. A sociobehavioral questionnaire was administered by interviewers. Selected DUs were asked to self-collect a fingerprick blood sample on blotting paper. RESULTS: Of all DUs selected, 1462 (75%) accepted to participate. HCV seroprevalence was 59.8% [95% CI: 50.7–68.3]. Of DUs under 30 years, 28% were HCV seropositive. Of HCV-infected DUs, 27% were unaware of their status. In the month prior to interview, 13% of DUs shared a syringe, 38% other injection parapharnelia and 81% shared a crack pipe. In multivariate analysis, factors independently associated with HCV seropositivity were age over 30, HIV seropositivity, having ever injected drugs, opiate substitution treatment (OST), crack use, and precarious housing. CONCLUSION: This is the first time that blood testing combined to GWSM is applied to a DUs population, which improve the estimate of HCV prevalence. HCV seroprevalence is high, indeed by the youngest DUs. And a large proportion of DUs are not aware of their status. Our multivariate analysis identifies risk factors such as crack consumption and unstable housing.
format Text
id pubmed-2733898
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27338982009-08-28 A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design Jauffret-Roustide, Marie Le Strat, Yann Couturier, Elisabeth Thierry, Damien Rondy, Marc Quaglia, Martine Razafandratsima, Nicolas Emmanuelli, Julien Guibert, Gaelle Barin, Francis Desenclos, Jean-Claude BMC Infect Dis Research Article BACKGROUND: Epidemiology of HCV infection among drug users (DUs) has been widely studied. Prevalence and sociobehavioural data among DUs are therefore available in most countries but no study has taken into account in the sampling weights one important aspect of the way of life of DUs, namely that they can use one or more specialized services during the study period. In 2004–2005, we conducted a national seroepidemiologic survey of DUs, based on a random sampling design using the Generalised Weight Share Method (GWSM) and on blood testing. METHODS: A cross-sectional multicenter survey was done among DUs having injected or snorted drugs at least once in their life. We conducted a two stage random survey of DUs selected to represent the diversity of drug use. The fact that DUs can use more than one structure during the study period has an impact on their inclusion probabilities. To calculate a correct sampling weight, we used the GWSM. A sociobehavioral questionnaire was administered by interviewers. Selected DUs were asked to self-collect a fingerprick blood sample on blotting paper. RESULTS: Of all DUs selected, 1462 (75%) accepted to participate. HCV seroprevalence was 59.8% [95% CI: 50.7–68.3]. Of DUs under 30 years, 28% were HCV seropositive. Of HCV-infected DUs, 27% were unaware of their status. In the month prior to interview, 13% of DUs shared a syringe, 38% other injection parapharnelia and 81% shared a crack pipe. In multivariate analysis, factors independently associated with HCV seropositivity were age over 30, HIV seropositivity, having ever injected drugs, opiate substitution treatment (OST), crack use, and precarious housing. CONCLUSION: This is the first time that blood testing combined to GWSM is applied to a DUs population, which improve the estimate of HCV prevalence. HCV seroprevalence is high, indeed by the youngest DUs. And a large proportion of DUs are not aware of their status. Our multivariate analysis identifies risk factors such as crack consumption and unstable housing. BioMed Central 2009-07-16 /pmc/articles/PMC2733898/ /pubmed/19607712 http://dx.doi.org/10.1186/1471-2334-9-113 Text en Copyright ©2009 Jauffret-Roustide et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Jauffret-Roustide, Marie
Le Strat, Yann
Couturier, Elisabeth
Thierry, Damien
Rondy, Marc
Quaglia, Martine
Razafandratsima, Nicolas
Emmanuelli, Julien
Guibert, Gaelle
Barin, Francis
Desenclos, Jean-Claude
A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design
title A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design
title_full A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design
title_fullStr A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design
title_full_unstemmed A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design
title_short A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design
title_sort national cross-sectional study among drug-users in france: epidemiology of hcv and highlight on practical and statistical aspects of the design
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733898/
https://www.ncbi.nlm.nih.gov/pubmed/19607712
http://dx.doi.org/10.1186/1471-2334-9-113
work_keys_str_mv AT jauffretroustidemarie anationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT lestratyann anationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT couturierelisabeth anationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT thierrydamien anationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT rondymarc anationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT quagliamartine anationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT razafandratsimanicolas anationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT emmanuellijulien anationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT guibertgaelle anationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT barinfrancis anationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT desenclosjeanclaude anationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT jauffretroustidemarie nationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT lestratyann nationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT couturierelisabeth nationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT thierrydamien nationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT rondymarc nationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT quagliamartine nationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT razafandratsimanicolas nationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT emmanuellijulien nationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT guibertgaelle nationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT barinfrancis nationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign
AT desenclosjeanclaude nationalcrosssectionalstudyamongdrugusersinfranceepidemiologyofhcvandhighlightonpracticalandstatisticalaspectsofthedesign